Silicon Laboratories Inc. — Form 10-K Summary
Period clarification: The supplied filing is for the fiscal year ended December 30, 2023, not 2022 Q4. Fiscal 2023 and fiscal 2022 each comprised 52 weeks.
Business context
Silicon Labs is a fabless semiconductor company focused on mixed-signal wireless products, software and development tools for Internet of Things applications. It reports one operating segment and groups revenue into Industrial & Commercial and Home & Life. Its former infrastructure and automotive business was sold in 2021; those results appear as discontinued operations in fiscal 2021.
Financial results and liquidity
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $782.3 million | $1,024.1 million |
| Gross profit / margin | $460.6 million / 58.9% | $642.6 million / 62.7% |
| Operating income (loss) | $(24.2) million | $119.3 million |
| Net income (loss) from continuing operations | $(34.5) million | $91.4 million |
| Diluted EPS | $(1.09) | $2.54 |
| Cash flow from operating activities | $(30.3) million | $141.3 million |
- Revenue fell 23.6%. Industrial & Commercial revenue declined 13.4% to $496.6 million; Home & Life fell 36.6% to $285.7 million. Management cited weak demand and customer inventory reductions.
- Gross margin fell 3.8 percentage points, primarily due to product mix and product cost variations. Operating expenses declined $38.6 million, but remained 62.0% of revenue versus 51.1% in FY2022.
- At year-end, cash and cash equivalents were $227.5 million and short-term investments were $211.7 million, totaling $439.2 million, versus $1.192 billion a year earlier. Net cash used in investing activities was $469.8 million, largely reflecting net sales and maturities of marketable securities; financing activities used $711.9 million.
- Inventory rose to $194.3 million from $100.4 million; days of inventory increased to 407 from 90. Accounts receivable was $29.3 million and days sales outstanding was 30.
- The company ended the year with $45.0 million drawn on its $400 million revolving facility; the $535 million 2025 convertible notes were settled in 2023 with cash and shares. The company repurchased approximately 1.5 million shares for $213.0 million during FY2023.
Material changes, outlook and risks
- Management described a softening market, elevated customer inventories, order cancellations and requests for delivery changes or price and payment concessions. Average selling prices increased overall year over year, while unit volumes declined.
- In Q4 FY2023, the company reduced its workforce by approximately 10%, recording $9.1 million in employee separation costs. Cost actions also included reducing variable compensation, contract labor and non-essential travel.
- For Q1 FY2024, management forecast revenue of $100–$110 million, gross margin of 52%, operating expenses of $118 million, and diluted loss per share of $1.89–$2.05. It expected R&D spending to remain relatively stable and SG&A to rise sequentially.
- Internal controls: Management identified a material weakness in inventory valuation controls, tied to reliance on demand forecasts without sufficient management review. Management said it had not caused material errors and was designing remediation. Management concluded disclosure controls and internal control over financial reporting were ineffective; the auditor issued an adverse opinion on internal control, while giving an unqualified opinion on the financial statements.
- Operating risks: The filing highlights semiconductor cyclicality, uncertain demand and inventory obsolescence, intense competition, and dependence on third-party manufacturing, assembly and testing, primarily in Asia. Geopolitical disruption involving China and Taiwan could affect supply. Two distributors accounted for 49% of FY2023 revenue; no end customer exceeded 10%. 88% of revenue was derived from outside the U.S.
- Contingency: The company is appealing a Norwegian tax assessment of approximately 141.3 million kroner ($13.9 million) relating to 2013 transfer pricing. It disputes the assessment and believes its position is more likely than not to be sustained, but an unfavorable outcome could materially affect financial statements. The company said other ordinary-course legal proceedings are not expected to have a material adverse effect.
- Other notable items include a $16.0 million equity-method loss, primarily from selling an investment, and an effective tax rate of (29.9)% despite a $7.9 million tax provision. The filing reports a $14.3 million unpaid U.S. transition-tax balance due between April 2024 and April 2025.
Important facts for investors to verify
- Whether inventory valuation controls have been remediated and whether inventory levels, write-downs and demand forecasts improve.
- Q1 FY2024 results against the stated revenue, gross-margin, expense and diluted-loss guidance.
- Whether customer inventory digestion and order volatility continue, particularly in Home & Life.
- Cash generation and liquidity after debt settlement and repurchases, including the availability and terms of revolving-credit borrowings.
- Exposure to distributor concentration and Asia-based supply, and the status and potential financial impact of the Norwegian tax appeal.